Year: 2023
Rising demand for intra-oral flat panel sensors in dental imaging is a key factor driving Intra-Oral Flat Panel Sensor market revenue growth
Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global intra-oral flat panel sensor market size was USD 337 Million in 2022 and is expected to register a steady revenue CAGR of 4% during the forecast period, according to latest analysis by Emergen Research. Rising demand for intra-oral flat panel sensors in dental imaging is a key factor driving market revenue growth. Intra-oral flat panel sensors are critical diagnostic components that are designed to be placed within the patient’s oral cavity. These sensors can collect very detailed images that provide the dentist with crucial diagnostic information. In addition, increasing use of dental imaging technology due to rising prevalence...
Inductive Encoder Market Growth CAGR 8.3% During 2022-2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Rising demand for inductive encoders in industrial automation is a major factor driving the Inductive Encoder market revenue growth.
Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global inductive encoder market size was USD billion in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of inductive encoders in industrial automation equipment such as robotic arms, actuators, conveyors, and other moving components are driving market revenue growth.Inductive encoder is designed to detect accurate, precise, and calibrated positions. Globally, an array of industries is adopting the industry ‘4.0’ paradigm, which frames development of various digital technologies as the fourth industrial revolution. Modern industrial...
Global Power Steering Pump Market Size Worth USD 5.02 Billion in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Increasing focus on considering enhanced Noise, Vibration, and Harshness (NVH) control and integration of sensor technologies is a major factor driving the Power Steering Pump market revenue growth.
Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global power steering pump market size was USD 1.74 Billion in 2022 and is expected to register a revenue CAGR of 3.1% during the forecast period, according to latest analysis by Emergen Research. Increasing focus on considering enhanced Noise, Vibration, and Harshness (NVH) control in power steering pump design is a major factor driving the market revenue growth. Manufacturers are employing advanced techniques, such as improved pump rotor profiles, vibration-dampening technologies, and noise reduction measures, to minimize noise and vibration levels.
This ensures a smoother and quieter...
SEALSQ Appoints Vice President of Global Sales
Written by Customer Service on . Posted in Public Companies.
Tortola, British Virgin Islands, Dec. 26, 2023 (GLOBE NEWSWIRE) —
SEALSQ Appoints Vice President of Global Sales
December 26, 2023: SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced the appointment of Franck Buonanno as Vice President of Global Sales for its Semiconductor and PKI activities, effective immediately.
Mr. Buonanno joined WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN; Nasdaq: WKEY), SEALSQ’s parent company, in August 2021 as Director of Sales for Europe. In his new role as Vice President of Global Sales for SEALSQ, Mr. Buonanno will be responsible for leading the Company’s global sales efforts.
With a career spanning three decades...
iBio Amends and Extends Maturity of Credit Agreement
Written by Customer Service on . Posted in Public Companies.
– Extends maturity date to March 29, 2024 –
– Allows for more time to complete planned divestiture of legacy CDMO business –
BRYAN, Texas and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced its wholly owned subsidiary, iBio CDMO LLC, and its lender, Woodforest National Bank (“Woodforest”), have entered into an amendment (the “Amendment”) to the Credit Agreement dated November 1, 2021 (the “Agreement”), extending the Agreement’s maturity date from December 31, 2023 to the earlier March 29, 2024, or the acceleration of maturity of the term loan in accordance with the Credit Agreement.
“We are pleased to have worked constructively with Woodforest to execute this amendment and extension of the maturity...
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
Written by Customer Service on . Posted in Mergers And Acquisitions.
Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading Oncology Franchise
Lead Program, RYZ101, in Phase 3 Development for Treatment of Gastroenteropancreatic Neuroendocrine Tumors and Early-stage Development for Treatment of Small Cell Lung Cancer and Potentially Other Tumor Types
Gains Robust IND Engine and State of the Art Radiopharmaceutical Manufacturing Capabilities
PRINCETON, N.J. and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (NASDAQ: RYZB) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in cash, for a total equity value of approximately $4.1 billion, or $3.6 billion...
Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Written by Customer Service on . Posted in Public Companies.
WAYNE, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 9, 2024, at 3:00 p.m. (PT).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com.
About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access,...
Fusion Acquisition Corp. II Announces Redemption of Shares
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — Fusion Acquisition Corp. II today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding shares of Class A common stock (the “Public Shares”), effective as of December 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation.
As of the close of business on December 28, 2023, the Public Shares will be deemed cancelled and will represent only the rights to receive the per-share redemption price of approximately $10.67 (after taking into account the removal of a portion of the accrued interest in the trust account to pay taxes and $100,000 for dissolution expenses).
In order to provide for the disbursement of funds from the trust account,...
AirNet Technology Inc. Announces Unaudited Financial Results for the First Half of 2023
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
BEIJING, Dec. 26, 2023 (GLOBE NEWSWIRE) — AirNet Technology Inc., formerly known as AirMedia Group Inc. (“AirNet” or the “Company”) (Nasdaq: ANTE), today announced its unaudited financial results for the first half of 2023.AIRNET TECHNOLOGY INC. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (In U.S. dollars in thousands, except share and per share data)
As of December 31,
As of June 30,
2022
2023
(Unaudited)
Assets
Current assets:
Cash and cash equivalents
$
2,700
$
132
Accounts receivable, net
1,421
552
Other current assets, net
65,072
28,527
Amount due from related parties
601
199
Total current assets
69,794
29,410
Property and equipment, net
10,885
10,447
Long-term investments, net
34,083
30,654
Long-term...
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
Written by Customer Service on . Posted in Public Companies.
PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that partner LianBio has entered into an agreement with Janssen Pharmaceutica NV (“Janssen”), a Johnson & Johnson company, whereby LianBio has assigned to Janssen LianBio’s exclusive rights to develop and commercialize potential first-in-class radioenhancer NBTXR3 in China, South Korea, Singapore, and Thailand.
“Our collaboration strategy for the development and commercialization of NBTXR3 is rooted in a shared commitment to delivering the potential first-in-class radioenhancer to millions of patients around the world,” said Laurent Levy, Nanobiotix...